Early assessment with 18F-2-fluoro-2-deoxyglucose positron emission tomography/computed tomography to predict short-term outcome in clear cell renal carcinoma treated with nivolumab

Table 1 Patients’ characteristics

Pt	Age	Histological Type	T stage	Tumor Grade	KPS	Prior Therapy
Pt	Age	Histological Type	T stage	Tumor Grade	KPS	1st	2nd	3rd	4th	5th	6th	7th
1	60s	clear	3	G2	90	SU	EVR	AXT	PAZ	TEM
2	70s	clear	1a	G1	100	INF	SFN	EVR	AXT
3	60s	clear	2a	G1	100	SU	AXT	EVR	PAZ	SFN
4	60s	clear	4	G1	100	SU	AXT	PAZ
5	60s	clear	1b	G2	100	INF	SFN	EVR	AXT	SU	TEM	PAZ
6	60s	clear	3a	G2	100	INF	SFN
7	60s	clear	1b	G1	90	SFN	EVR	AXT
8	60s	clear	3a	G2	100	SFN	AXT	EVR	SU
9	70s	clear	1b	G3	90	SFN	EVR

KPS Karnofsky performance status, SU Sunitinib, SFN Sorafenib, EVR Everolimus, AXT Axitinib, PAZ Pazopanib, TEM Temsirolimus, INF Interferon-alpha

ISSN: 1471-2407